# A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

> **NCT01366287** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-03882845
- **DRUG:** PF-03882845
- **DRUG:** PF-03882845

## Key facts

- **NCT ID:** NCT01366287
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366287, "A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01366287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*